|
|
||||||||
The Annals of Thoracic Surgery, Vol 38, 268-274, Copyright © 1984 by The Society of Thoracic Surgeons
LA Robinson, MV Braimbridge and DJ Hearse
Although few surgeons dispute the benefits of high-potassium crystalloid
cardioplegia, objective comparison of the efficacy of various formulations
is difficult in clinical practice. We compared four commonly used
cardioplegic solutions in the isolated rat heart (N = 6 for each solution)
subjected to 180 minutes of hypothermic (20 degrees C) ischemic arrest with
multidose cardioplegia (3 minutes every half-hour). The clinical solutions
studied were St. Thomas' Hospital solution, Tyers' solution, lactated
Ringer's solution with added potassium, and a balanced saline solution with
glucose and potassium. Postischemic recovery of function was expressed as a
percentage of preischemic control values. Release of creatine kinase during
reperfusion was measured as an additional index of protection. St. Thomas'
Hospital solution provided almost complete recovery of all indexes of
cardiac function following ischemia including 88.1 +/- 1.6% recovery of
aortic flow, compared with poor recovery for the Tyers', lactated Ringer's,
and balanced saline solutions (20.6 +/- 6.5%, 12.5 +/- 6.4%, and 9.6 +/-
4.2%, respectively) (p less than 0.001). Spontaneous defibrillation was
rapid (less than 1 minute) and complete (100%) in all hearts in the St.
Thomas' Hospital solution group, but much less satisfactory with the other
formulations. Finally, St. Thomas' Hospital solution had a low postischemic
level of creatine kinase leakage, contrasting with significantly higher
enzyme release in the other solutions tested (p less than 0.001). Although
differences in composition are subtle, all potassium crystalloid
cardioplegic solutions are not alike in the myocardial protection they
provide. Comparative studies under controlled conditions are important to
define which formulation is superior for clinical application.
ARTICLES
Comparison of the protective properties of four clinical crystalloid cardioplegic solutions in the rat heart
This article has been cited by other articles:
![]() |
C. Kennergren, V. Mantovani, L. Strindberg, E. Berglin, A. Hamberger, and P. Lonnroth Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E788 - E794. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Chambers and D. J. Hearse Developments in cardioprotection: ""polarized"" arrest as an alternative to ""depolarized"" arrest Ann. Thorac. Surg., November 1, 1999; 68(5): 1960 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Robinson, G. D. Schwarz, D. B. Goddard, W. H. Fleming, and T. A. Galbraith Myocardial Protection for Acquired Heart Disease Surgery: Results of a National Survey Ann. Thorac. Surg., February 1, 1995; 59(2): 361 - 372. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |